-+ 0.00%
-+ 0.00%
-+ 0.00%

Virax Biolabs Files Initial Beneficial Ownership Statement for Chief Scientific Officer Clement Monteil

PUBT·10/21/2026 12:13:00
Listen to the news
Virax Biolabs Files Initial Beneficial Ownership Statement for Chief Scientific Officer Clement Monteil
  • Virax Biolabs Chief Scientific Officer Clement Monteil disclosed stock options covering 4,860 ordinary shares in an initial beneficial ownership statement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-427235), on October 21, 2026, and is solely responsible for the information contained therein.